These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 395307)

  • 21. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody dependent cellular cytotoxicity (ADCC) against human erythrocytes, mediated by blood group alloantibodies: a model for the role of antigen density in target cell lysis.
    Northoff H; Kluge A; Resch K
    Z Immunitatsforsch Immunobiol; 1978; 154(1):15-33. PubMed ID: 74918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.
    Shiloni E; Eisenthal A; Sachs D; Rosenberg SA
    J Immunol; 1987 Mar; 138(6):1992-8. PubMed ID: 3493293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inhibition of expontaneous cytotoxicity and antibody dependency by rheumatoid synovial fluid].
    Noguera Hernando E; Kreisler M; Durantez A; Larrea Gayarre A; de Landazuri MO; Cruz Martínez J
    Allergol Immunopathol (Madr); 1978; 6(3):253-62. PubMed ID: 717203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-donor cell-mediated responses. Pretransplant lymphocyte-mediated cytotoxicity (LMC) and antibody-dependent cell-mediated cytotoxicity (ADCC) in kidney transplantation.
    Myburgh JA; Smit JA
    Transplant Proc; 1978 Jun; 10(2):425-7. PubMed ID: 354131
    [No Abstract]   [Full Text] [Related]  

  • 27. Alloantibodies and the outcome of cadaver kidney allografts.
    Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N
    Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
    Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
    J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretransplant assays of alloimmunity in predicting renal graft outcome.
    Gailiunas P; Person A; Suthanthiran M; Carpenter CB; Garovoy MR
    Proc Clin Dial Transplant Forum; 1977; 7():1-3. PubMed ID: 356029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential changes in NK and ADCC effector cell function after organ transplantation in man.
    Hegarty JH; Ramsden CW; Dowd PS; Giles GR; Guillou PJ
    Biomed Pharmacother; 1983; 37(6):266-70. PubMed ID: 6367846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-HLA-A, B, C and DR antibodies in renal transplant recipients.
    Akiyama N; Kusaba R; Osawa N; Inou T; Kawamura A
    Jpn J Exp Med; 1980 Jun; 50(3):205-11. PubMed ID: 7001096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection.
    Mayer TG; Fuller AA; Fuller TC; Lazarovits AI; Boyle LA; Kurnick JT
    J Immunol; 1985 Jan; 134(1):258-64. PubMed ID: 3155462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis.
    Tripathy NK; Upadhyaya S; Sinha N; Nityanand S
    J Rheumatol; 2001 Apr; 28(4):805-8. PubMed ID: 11327255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
    Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S
    Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of antibody-dependent cellular cytotoxicity by artificial immune complexes and pathological sera.
    Howat JM; Moore M; Hilton AM; Kimber I
    Immunology; 1979 Jun; 37(2):467-75. PubMed ID: 468310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithymocyte globulin-induced prolongation of human renal allograft survival in recipients with in vitro steroid-resistant ADCC.
    Dumble LJ; Clunie GJ; Macdonald IM; Bowes LG; Kincaid-Smith P
    Transplant Proc; 1984 Dec; 16(6):1503-5. PubMed ID: 6390854
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: effects of recombinant interleukin 2 on human effector cell lysis of human B-cell tumors.
    Biddle WC; Pancook J; Goldrosen M; Han T; Foon KA; Vaickus L
    Cancer Res; 1990 May; 50(10):2991-6. PubMed ID: 2334902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between antibody-dependent cell-mediated cytotoxicity due to anti-HTLV-1 and negative signal of major histocompatibility complex class I antigens on adult T-cell leukemia cell lines.
    Komatsu F; Tamiya H
    Oncol Res; 1998; 10(2):59-67. PubMed ID: 9666513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-HLA antibodies in nephropathic patients].
    Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
    G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.